Cancer Research Cancer Health Disparities Conference 2009  SU2C
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dimitroff, C. J.
Right arrow Articles by Rubin, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dimitroff, C. J.
Right arrow Articles by Rubin, M. A.
[Cancer Research 65, 5750-5760, July 1, 2005]
© 2005 American Association for Cancer Research


Cell and Tumor Biology

Identification of Leukocyte E-Selectin Ligands, P-Selectin Glycoprotein Ligand-1 and E-Selectin Ligand-1, on Human Metastatic Prostate Tumor Cells

Charles J. Dimitroff1,3, Leyla Descheny1, Natalia Trujillo1, Robert Kim2, Vuong Nguyen2, Wei Huang2,3, Kenneth J. Pienta4, Jeffery L. Kutok2,3 and Mark A. Rubin2,3

1 Harvard Skin Disease Research Center, Department of Dermatology, and 2 Department of Pathology, Brigham and Women's Hospital; 3 Harvard Medical School, Boston, Massachusetts; and 4 Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan

Requests for reprints: Charles J. Dimitroff, Harvard Institutes of Medicine, Room 650, 77 Avenue Louis Pasteur, Boston, MA 02115. Phone: 617-525-5693; Fax: 617-525-5571; E-mail: cdimitroff{at}rics.bwh.harvard.edu.

Prostate tumor cells, which characteristically metastasize to bone, initiate binding interactions with bone marrow endothelium under blood flow conditions through binding interactions with E-selectin. We hypothesized that E-selectin ligands on prostate tumor cells are directly associated with bone-metastatic potential. In this report, we elucidate the identity of E-selectin ligands on human metastatic prostate tumor cells and examine their association with prostate tumor progression and metastasis in vivo. To our surprise, we found that the E-selectin-binding form of P-selectin glycoprotein ligand-1 (PSGL-1) is expressed on the human bone-metastatic prostate tumor MDA PCa 2b cell line. Interestingly, we also found that human prostate tumor cells derived from bone, lymph node, and brain metastases expressed another leukocyte E-selectin ligand, E-selectin ligand-1 (ESL-1). Immunohistochemical analysis of PSGL-1 and ESL-1 in normal prostate tissue and in localized and metastatic prostate tumors revealed that ESL-1 was principally localized to intracellular cell membrane and expressed on all normal and malignant prostate tissue, whereas PSGL-1 was notably detected on the surfaces of bone-metastatic prostate tumor cells. These findings implicate a functional role of PSGL-1 in the bone tropism of prostate tumor cells and establish a new perspective into the molecular mechanism of human prostate tumor metastasis.




This article has been cited by other articles:


Home page
GlycobiologyHome page
S. R Barthel, J. D Gavino, G. K Wiese, J. M Jaynes, J. Siddiqui, and C. J Dimitroff
Analysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectin
Glycobiology, October 1, 2008; 18(10): 806 - 817.
[Abstract] [Full Text] [PDF]


Home page
IBMS BoneKEyHome page
G. J. Strewler
Cancer Stem Cells and Bone Metastasis
IBMS BoneKEy, September 1, 2008; 5(9): 308 - 322.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. E. Gainers, L. Descheny, S. R. Barthel, L. Liu, M.-A. Wurbel, and C. J. Dimitroff
Skin-Homing Receptors on Effector Leukocytes Are Differentially Sensitive to Glyco-Metabolic Antagonism in Allergic Contact Dermatitis
J. Immunol., December 15, 2007; 179(12): 8509 - 8518.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. R. Langley and I. J. Fidler
Tumor Cell-Organ Microenvironment Interactions in the Pathogenesis of Cancer Metastasis
Endocr. Rev., May 1, 2007; 28(3): 297 - 321.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Gout, C. Morin, F. Houle, and J. Huot
Death Receptor-3, a New E-Selectin Counter-Receptor that Confers Migration and Survival Advantages to Colon Carcinoma Cells by Triggering p38 and ERK MAPK Activation.
Cancer Res., September 15, 2006; 66(18): 9117 - 9124.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
J. Holgersson and J. Lofling
Glycosyltransferases involved in type 1 chain and Lewis antigen biosynthesis exhibit glycan and core chain specificity
Glycobiology, July 1, 2006; 16(7): 584 - 593.
[Abstract] [Full Text] [PDF]


Home page
IBMS BoneKEyHome page
G. J. Strewler
The Stem Cell Niche and Bone Metastasis
IBMS BoneKEy, May 1, 2006; 3(5): 19 - 29.
[Abstract] [Full Text] [PDF]


Home page
IBMS BoneKEyHome page
C. J. Dimitroff
Sharing the Same Vascular Addressins for Osteotropic Behavior of Hematopoietic Progenitor Cells and Cancer
IBMS BoneKEy, October 1, 2005; 2(10): 16 - 19.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.